GSC
ANIK icon

Ground Swell Capital’s Anika Therapeutics ANIK Stock Holding History

Ground Swell Capital’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$7K Buy
+200
New +$8.64K 0.01% 1237

Other funds holding ANIK

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return

Ground Swell Capital's ANIK Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Anika Therapeutics (ANIK) in Q3 2014: 200 shares worth $7K. The stake represents 0.01% of the portfolio and ranks #1237 among its holdings.

153 funds tracked by Wall St. Rank hold ANIK as of Q3 2014.

  • Ground Swell Capital held 200 shares of Anika Therapeutics worth $7K as of Q3 2014.
  • Anika Therapeutics was a new Ground Swell Capital position in Q3 2014.
  • Anika Therapeutics made up 0.01% of Ground Swell Capital's portfolio in Q3 2014, its #1237 holding.
  • 153 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.